Krupp LB, Rizvi S: Symptomatic therapy for underrecognized manifestations of multiple sclerosis. Practical Issues in the Management of Multiple Sclerosis. Neurology: 2002, 32-29 Krupp LB, Alvarez LA, LaRocca NG, Scheinberg LC: Clinical characteristics of fatigue in multiple sclerosis. Arch Neurol 1988;45:435-437 Krupp LB, LaRocca NG, Muir-Nash J, Steinberg AD: The fatigue severity scale applied to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol 1989;46:1121-1123 Pepper C, Krupp LB, Friedberg F, Doscher C, Coyle PK: Comparison of psychiatric characteristics in chronic fatigue syndrome, multiple sclerosis and depression. Journal of Neuropsychiatry and Clinical Neurosciences 1993;5:1-7 Krupp LB, Sliwinski M, Masur D, Friedberg F, Coyle PK: Cognitive functioning and depression in patients with chronic fatigue syndrome and multiple sclerosis. Arch Neurol 1994;51:705-710 Krupp LB, Coyle PK, Doscher C, Miller A, Cross AH, Jandorf L, Halper J, Johnson B, Morgante L, Grimson R: Fatigue therapy in multiple sclerosis: results of a double blind randomized parallel trial of amantadine, pemoline and placebo. Neurology 1995;45:1956-1961 Geisler MW, Sliwinski M, Coyle PK, Masur DM, Doscher C, Krupp LB: The effects of amantadine and pemoline on cognitive functioning in multiple sclerosis. Arch Neurol 1996;53:185-188 Krupp LB, Advances in the treatment of multiple sclerosis. Western Journal of Medicine 1996;165:247 Krupp LB, Pollina DA: Mechanisms and management of fatigue in progressive neurological disorders. Current Opinion in Neurology 1996;9:456-460 Miller AE, Morgante LA, Buchwald LY, Nutile SM, Coyle PK, Krupp, LB, Doscher CA: A multicenter, randomized, double-bline placebo-controlled trial of influenza immunization in multiple sclerosis. Neurology 1997;48:312-314 Jacobs L, Wende KE, Brownscheidle CM, Apatoff B, Coyle PK, Goodman A, Gottesman MH, Granger CV, Greenberg SJ, Herbert J, Krupp LB, Lava NS, Mihai C, Miller AE, Perel A, Snyder DH, New York State Multiple Sclerosis Consortium: A profile of multiple sclerosis: the New York State multiple sclerosis consortium. Multiple Sclerosis 1999:5:369-376 Krupp LB, Elkins LE: Fatigue and declines in cognitive functioning in multiple sclerosis. Neurology 2000;55:934-939 Schwid S, Goodman A, Apatoff B, Coyle P, Jacobs L, Krupp L, Miller A, Wende K, Brownscheidle C, New York State Multiple Sclerosis Consortium: Quantitative functional measures are more sensitive to worsening MS than traditional measures. Neurology 2000;55:1901-1903 Pan JW, Krupp LB, Elkins L, Coyle PK: Cognitive dysfunction lateralizes with NAA in multiple sclerosis. Applied Neuropsychology 2001;8:155-160 Krupp LB: Fatigue in MS. In: Rudick RA, Goodkin DE: Multiple Sclerosis: Experimental and Applied Therapeutics. Martin Dunitz: London. 1999;467-4744. Krupp LB: Management of persons with multiple sclerosis. In: Ozer MN ed. Management of persons with chronic neurologic illness. Butterworth Heinemann: New York. 2000;199-212 Krupp LB, Christodoulou C: Fatigue in multiple sclerosis. Current Neurology and Neuroscience Reports 2001;1:295-298 Krupp LB, Elkins LE, Strober LS, Scherl W, Cianciulli C: Explicit and implicit verbal memory in multiple sclerosis: implications for treatment. JINS 2001